This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

The Medication Experience Study

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Steven R. Feldman, Wake Forest University Health Sciences
ClinicalTrials.gov Identifier:
NCT01702883
First received: October 4, 2012
Last updated: March 8, 2017
Last verified: March 2017
October 4, 2012
March 8, 2017
October 2012
July 2015   (Final data collection date for primary outcome measure)
The primary measure will be adherence as measured by pharmacy refills in each group. [ Time Frame: 12 months ]
Same as current
Complete list of historical versions of study NCT01702883 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
The Medication Experience Study
Using an Internet Survey to Improve Patient Adherence in Chronic Disease
The purpose of this study is to evaluate whether participation in an Internet-based intervention helps improve medication use.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Participant, Investigator
Primary Purpose: Other
  • Hypertension
  • Elevated Cholesterol
  • Diabetes
  • Depression
Other: Internet Survey
prompt to complete internet survey
Other Name: internet surveys
  • No Intervention: Control
    Randomization occurs after enrollment survey has been completed. This group will not receive the internet intervention for the twelve months. They will be asked to complete the final survey.
  • Experimental: Intervention Group A
    Randomization occurs after enrollment survey has been completed. Upon secondary randomization at week eight, this group will continue to receive weekly internet surveys for the entire twelve months. They will be asked to complete the final survey.
    Intervention: Other: Internet Survey
  • Experimental: Intervention Group B
    Randomization occurs after enrollment survey has been completed. This group will complete weekly internet surveys for eight weeks. Upon secondary randomization at week eight, this group will begin to receive monthly internet surveys. They will be asked to complete the final survey.
    Intervention: Other: Internet Survey
  • Experimental: Intervention Group C
    Randomization occurs after enrollment survey has been completed. This group will complete weekly internet surveys for eight weeks. Upon secondary randomization at week eight, the group will not receive any more internet surveys. They will be asked to complete the final survey.
    Intervention: Other: Internet Survey
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
186
December 2017
July 2015   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Any male or female 18 years or older, filling prescriptions for oral medications for hypertension, high cholesterol, diabetes, or depression at the Downtown Health Plaza, Piedmont Plaza, or Cancer Center Pharmacies.

Exclusion Criteria:

  • Inability to complete Internet surveys due to inadequate Internet access, not understanding a survey written in English, or lack of computer skills.
  • Patient does not intend to continue using the same WFBMC-affiliated pharmacy for the next 12 months.
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01702883
20789
No
Not Provided
Not Provided
Not Provided
Steven R. Feldman, Wake Forest University Health Sciences
Wake Forest University
Not Provided
Principal Investigator: Steve R Feldman, MD, PhD Wake Forest University Health Sciences
Wake Forest University Health Sciences
March 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP